Build status - In Progress

CART-38 in Adult AML and MM Patients - 1

Investigational Treatment for Adult Blood Cancers

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

See protocol section 2 See protocol section 2 See protocol section 4

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

This study investigates the effects of an investigational treatment in adults with acute myeloid leukemia (AML) and multiple myeloma (MM).

The study aims to assess the safety and potential benefits of the investigational treatment for individuals living with these conditions.

  • Who can participate: Adults aged 18 and older with acute myeloid leukemia or multiple myeloma may be eligible. Further eligibility criteria are being determined.
  • Study details: Participants will be involved in activities to evaluate the effects on AML and MM.
Updated on 30 Jun 2025. Study ID: 679878443
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research